Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma

Autor: Eertink, J. J., Zwezerijnen, G. J. C., Heymans, M. W., Pieplenbosch, S., Wiegers, S. E., Dührsen, U., Hüttmann, A., Kurch, L., Hanoun, C., Lugtenburg, P. J., Barrington, S. F., Mikhaeel, N. G., Ceriani, L., Zucca, E., Czibor, S., Györke, T., Chamuleau, M. E. D., Hoekstra, O. S., de Vet, H. C. W., Boellaard, R., Zijlstra, J. M.

Publikováno v: In Blood 22 June 2023 141(25):3055-3064

Perioperative PET/CT lymphoscintigraphy and fluorescent real-time imaging for sentinel lymph node mapping in early staged colon cancer.

Autor: Ankersmit, M.¹ (AUTHOR) m.ankersmit1@vumc.nl, Hoekstra, O. S.² (AUTHOR), van Lingen, A.² (AUTHOR), Bloemena, E.³ (AUTHOR), Jacobs, M. A. J. M.⁴ (AUTHOR), Vugts, D. J.² (AUTHOR), Bonjer, H. J.¹ (AUTHOR), van Dongen, G. A. M. S.² (AUTHOR), Meijerink, W. J. H. J.⁵ (AUTHOR)

Publikováno v: European Journal of Nuclear Medicine & Molecular Imaging. Jul2019, Vol. 46 Issue 7, p1495-1505. 11p. 1 Color Photograph, 1 Diagram, 3 Charts, 2 Graphs.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Correction to:[89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer (European Journal of Nuclear Medicine and Molecular Imaging, (2020), 47, 4, (849-859), 10.1007/s00259-019-04555-6)

Autor: van Helden, E. J., Elias, S. G., Gerritse, S. L., van Es, S. C., Boon, E., Huisman, M. C., van Grieken, N. C.T., Dekker, H., van Dongen, G. A.M.S., Vugts, D. J., Boellaard, R., van Herpen, C. M.L., de Vries, E. G.E., Oyen, W. J.G., Brouwers, A. H., Verheul, H. M.W., Hoekstra, O. S., der Houven van Oordt, C. W.Menke van

Publikováno v: van Helden, E J, Elias, S G, Gerritse, S L, van Es, S C, Boon, E, Huisman, M C, van Grieken, N C T, Dekker, H, van Dongen, G A M S, Vugts, D J, Boellaard, R, van Herpen, C M L, de Vries, E G E, Oyen, W J G, Brouwers, A H, Verheul, H M W, Hoekstra, O S & der Houven van Oordt, C W M V 2020, ' Correction to : [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer (European Journal of Nuclear Medicine and Molecular Imaging, (2020), 47, 4, (849-859), 10.1007/s00259-019-04555-6) ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 47, no. 10, pp. 2481 . https://doi.org/10.1007/s00259-020-04908-6

The Electronic Supplementary Materials are missing in the original article. Kindly check the Electronic Supplementary Materials in this article. The Publisher regrets this error.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10172::0c0938e5110305b00cc0d60e8bed533c
https://research.vumc.nl/en/publications/0c4bd5ae-9627-44b4-9087-a375c3e76a80

Aberrant patterns of PET-CT response for diffuse large B-cell lymphoma patients with MYC rearrangement

Autor: Eertink, J., Celik, F., Huijbregts, J., Arens, A. I. J., Wiegers, S. E., Burggraaff, C. N., Hoekstra, O. S., Stroobants, S., Boellaard, R., de Vet, H. C. W., Chamuleau, M. E. D., Zijlstra, J. M.

Publikováno v: Eertink, J, Celik, F, Huijbregts, J, Arens, A I J, Wiegers, S E, Burggraaff, C N, Hoekstra, O S, Stroobants, S, Boellaard, R, de Vet, H C W, Chamuleau, M E D & Zijlstra, J M 2020, ' Aberrant patterns of PET-CT response for diffuse large B-cell lymphoma patients with MYC rearrangement ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 47, no. SUPPL 1, pp. S126-S126 .
European Journal of Nuclear Medicine and Molecular Imaging, 47(SUPPL 1), S126-S126. Springer Verlag

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5165e95842c595dc6663fd51bdf787cc
https://research.vumc.nl/en/publications/ce2210cc-6067-408a-b252-14c987d89ac3